-
1Academic Journal
Συγγραφείς: T. A. Gendugov, A. A. Glushko, A. A. Ozerov, L. I. Shcherbakova, Т. А. Гендугов, А. А. Глушко, А. А. Озеров, Л. И. Щербакова
Συνεισφορές: This work did not have funding from outside organizations, Данная работа не имела финансирования от сторонних организаций
Πηγή: Pharmacy & Pharmacology; Том 8, № 4 (2020); 242-254 ; Фармация и фармакология; Том 8, № 4 (2020); 242-254 ; 2413-2241 ; 2307-9266 ; 10.19163/2307-9266-2020-8-4
Θεματικοί όροι: ORCA, pharmaceutical substance, stress testing, stress test modeling, thermolysis, photolysis, hydrolysis, high-performance liquid chromatography, photostability, thermalstability, GROMACS, фармацевтическая субстанция, стресс-тестирование, моделирование стресс-тестов, термолиз, фотолиз, гидролиз, высокоэффективная жидкостная хроматография, фотостабильность, термостабильность
Περιγραφή αρχείου: application/pdf
Relation: https://www.pharmpharm.ru/jour/article/view/729/620; https://www.pharmpharm.ru/jour/article/view/729/624; Государственная Фармакопея Российской Федерации. Изд. XIV. Т. 1. – М., 2018. [Электронный ресурс]. http://feml.scsml.rssi.ru/feml; ICH guidelines, Q1A (R2): Stability Testing of New Drug Substances and Products (Revision 2), International Conference on Harmonization; 2003. [Электронный ресурс]. – https://www.ema.europa.eu/en/documents/scientific–guideline/ich-q-1-r2-stability-testing-new-drugsubstances-products-step-5_en.pdf; ICH Guidance, Q1C: Stability Testing for New Drug Dosage Forms, International Conference on Harmonization. 1996. [Электронный ресурс]. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-c-stability-testingrequirements-new-dosage-forms-step-5_en.pdf; Existing Active Ingredients and Related Finished Products (CPMP/QWP/122/02 Rev. 1 corr), 2003. [Электронный ресурс]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003466.pdf; ICH Guidance, Q1B: Photostability Testing of New Drug Substances and Products, International Conference on Harmonization, 1998. [Электронный ресурс] https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-1-b-photostability-testing-new-active-substancesmedicinal-products-step-5_en.pdf; FDA Guidance for Industry, INDs for Phase II and III Studies – Chemistry, Manufacturing and Controls Information, Food and Drug Administration, 2003. [Электронный ресурс]. – https://www.fda.gov/media/70822/download; Klauda, J.B., Venable, R.M., Freites, J.A., O’Connor, J.W., Tobias, D.J., Mondragon-Ramirez, C., Vorobyov, I., MacKerell, Jr., A.D., Pastor R.W. Update of the CHARMM All-Atom Additive Force Field for Lipids: Validation on Six Lipid Types // Journal of Physical Chemistry B. – 2010. – V. 114, No23. – Р. 7830–7843. DOI:10.1021/jp101759q; Abraham M.J., Murtola T., Schulz R., Páll S., Smith J.C., Hess B., Lindahl E. GROMACS: High performance molecular simulations through multi–level parallelism from laptops to supercomputers // SoftwareX. – 2015. – V. 1–2. – P. 19–25. DOI:10.1016/j.softx.2015.06.001.; Zoete V., Cuendet M. A., Grosdidier A., Michielin O. SwissParam: a Fast Force Field Generation Tool For Small Organic Molecules // Journal of Computational Chemistry. – 2011. – V. 32, No 11. – P. 2359–2368. DOI:10.1002/jcc.21816.; Braga C., Travis K. P. A configurational temperature Nosé– Hoover thermostat // The Journal of Chemical Physics.–2005. – V. 123, No 11. – P.123. DOI:10.1063/1.2013227.; Neese F. Software update: The ORCA program system, version 4.0 // Wiley Interdisciplinary Reviews: Computational Molecular Science. – 2017. – Vol. 8, No 1.– P. e1327. DOI:10.1002/wcms.1327.; Bäcktorp C., Örnskov E., Ottosson J., Evertsson E., Remmelgas J., Broo A. Experimental and Quantum Chemical Evaluations of Pyridine Oxidation Under Drug Development Stress Test Conditions // Journal of Pharmaceutical Sciences. –2015. – V. 104 (12). – P. 4355–4364. DOI:10.1002/jps.24685; Szepesi G., Gazdag M., Mihályfi K. Selection of high– performance liquid chromatographic methods in pharmaceutical analysis // Journal of Chromatography A. – 1991. – V. 464. – P. 265–278. DOI:10.1016/s0021-9673(00)94245-6; Gazdag M., Szepesi G., Szeleczki E. Selection of high–performance liquid chromatographic methods in pharmaceutical analysis // Journal of Chromatography A. – 1988. – V. 454. – P. 83–94. DOI:10.1016/s0021-9673(00)88604-5; Carr G.P., Wahlich J.C. A practical approach to method validation in pharmaceutical analysis // Journal of Pharmaceutical and Biomedical Analysis. – 1990. – V. 8 (8–12). – P. 613–618. DOI:10.1016/0731-7085(90)80090-c; Jenke D.R. Chromatographic method validation: a review of common practices and procedures // Journal of Liquid Chromatography & Related Technologies. – 1996. – V. 19 (5). – P. 719–736. DOI:10.1080/10826079608005533; Iram F., Iram H., Iqbal A., Husain A. Forced Degradation Studies // Journal of Analytical & Pharmaceutical Research. – 2016. – V. 3, No 6. – P. 73. DOI:10.15406/japlr.2016.03.00073; Blessy M., Patel R.D., Prajapati P.N., Agrawal Y.K. Development of forced degradation and stability indicating studies of drugs – A review // Journal of Pharmaceutical Analysis. – 2014. – V. 4, No 3. – P. 159–165. DOI:10.1016/j.jpha.2013.09.003; Alsante K.M., Ando A., Brown R., et al. The role of degradant profiling in active pharmaceutical ingredients and drug products // Advanced Drug Delivery Reviews. – 2007. – V. 59, No1. – P. 29–37. DOI:10.1016/j.addr.2006.10.006; Piechocki J.T., Thoma K. Pharmaceutical Photostability and Stabilization Technology, Informa Healthcare. – CRC Press, publ. 2019. – 445p.; Singh R, Rehman Z. Current trends in forced degradation study for pharmaceutical product development. Journal of Pharmaceutical Education and Research. 2012;3(1):54–63.; https://www.pharmpharm.ru/jour/article/view/729